181011-676

CourtBoard of Veterans' Appeals
DecidedJune 25, 2019
Docket181011-676
StatusUnpublished

This text of 181011-676 (181011-676) is published on Counsel Stack Legal Research, covering Board of Veterans' Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
181011-676, (bva 2019).

Opinion

Citation Nr: AXXXXXXXX Decision Date: 06/25/19 Archive Date: 06/24/19

DOCKET NO. 181011-676 DATE: June 25, 2019

ORDER

New and relevant evidence has been received to reopen a claim for entitlement to service connection for Parkinson’s Disease, and to that extent only, the appeal is granted.

Entitlement to service connection for Parkinson's Disease is denied.

FINDINGS OF FACT

1. A July 2013 rating decision denied service connection for Parkinson’s disease. The Veteran did not perfect the appeal of that rating decision.

2. New evidence was received after the July 2013 denial that is relevant to the issue of entitlement to service connection for Parkinson’s disease.

3. The Veteran has not demonstrated actual exposure to an herbicide agent during his service, to include in the Republic of Korea.

4. The preponderance of the evidence is against finding that Parkinson’s Disease began during active service or is otherwise related to an in-service event.

CONCLUSIONS OF LAW

1. The criteria for readjudicating the claim for entitlement to service connection for Parkinson’s Disease have been met. Veterans Appeals Improvement and Modernization Act, Pub. L. No. 115-55, § 5108, 131 Stat. 1105 (2017).

2. The criteria for service connection for Parkinson’s Disease are not met. 38 U.S.C. §§ 1110, 1131, 5107; 38 C.F.R. §§ 3.102, 3.303, 3.307, 3.309.

REASONS AND BASES FOR FINDINGS AND CONCLUSIONS

On August 23, 2017, the President signed into law the Veterans Appeals Improvement and Modernization Act, Pub. L. No. 115-55 (to be codified as amended in scattered sections of 38 U.S.C.), 131 Stat. 1105 (2017), also known as the Appeals Modernization Act (AMA). This law creates a new framework for Veterans dissatisfied with VA’s decision on their claim to seek review. The Board is honoring the Veteran’s choice to participate in VA’s test program, RAMP, the Rapid Appeals Modernization Program.

The Veteran served on active duty from June 1972 to June 1974. The Veteran selected the Direct Claim lane when he submitted the RAMP election form. Accordingly, the June 2018 RAMP rating decision considered the evidence of record prior to the issuance of the RAMP rating decision. The Veteran timely appealed that RAMP rating decision to the Board and requested direct review of the evidence considered by the Agency of Original Jurisdiction (AOJ).

The new and material evidence issue regarding Parkinson’s disease has been recharacterized to indicate the new evidentiary standard under the AMA. Pub. L. No. 115-55, § 5108, 131 Stat. 1105, 1109.

1. Whether new and relevant evidence has been received to reopen a claim for entitlement to service connection for Parkinson’s Disease

The Veteran contends that he submitted new evidence to reopen a claim for service connection for Parkinson’s disease that is new and relevant and warrants readjudication of the issue.

VA will readjudicate a claim if new and relevant evidenced is presented or secured. AMA, Pub. L. No. 115-55, § 5108, 131 Stat. 1105, 1109. “Relevant evidence” is evidence that tends to prove or disprove a matter in issue. AMA, Pub. L. No. 115-55, § 101(35), 131 Stat. 1105, 1105.

The question in this case is whether the Veteran submitted evidence after the prior final denial of his claim for service connection for Parkinson’s disease in the legacy system, and if so, whether that evidence is new and relevant to his claim.

The Board finds the Veteran submitted new evidence after the prior final rating decision in the legacy system that is relevant to his claim. The Veteran submitted three medical nexus opinions, in May 2017, September 2017, and December 2017, which was after the July 2013 prior final rating decision. Those opinions were not already of record and may prove or disprove the nexus element of the claim for service connection for Parkinson’ s disease. Accordingly, readjudication of the claim is warranted.

2. Service connection for Parkinson’s Disease

Service connection may be established for a disability resulting from disease or injury incurred in or aggravated by active service. 38 U.S.C. §§ 1110, 1131; 38 C.F.R. § 3.303. To establish a service connection for a disability, a Veteran must show: (1) the existence of a present disability; (2) in-service incurrence or aggravation of a disease or injury; and (3) a causal relationship between the present disability and the disease or injury incurred or aggravated during service. Davidson v. Shinseki, 581 F.3d 1313 (Fed. Cir. 2009); Shedden v. Principi, 381 F.3d 1163 (Fed. Cir. 2004).

VA regulations provide that if a veteran was exposed to herbicide agents during active service, the following diseases shall be service connected if the requirements of 38 C.F.R. § 3.307(a) are met, even if there is no record of such disease during service: AL amyloidosis, chloracne or other acneform disease consistent with chloracne; type 2 diabetes (also known as Type II diabetes mellitus); Hodgkin’s disease; chronic lymphocytic leukemia (CLL); multiple myeloma; Non-Hodgkin’s lymphoma; acute and subacute peripheral neuropathy; porphyria cutanea tarda; prostate cancer; respiratory cancers (cancer of the lung, bronchus, larynx or trachea); soft tissue sarcoma (other than osteosarcoma, chondrosarcoma, Kaposi’s sarcoma, or mesothelioma), chronic B-cell leukemias, Parkinson’s disease, and ischemic heart disease. 38 C.F.R. § 3.309 (e).

The term herbicide agent means a chemical in an herbicide used in support of the United States and allied military operations in the Republic of Vietnam during the period beginning on January 9, 1962, and ending on May 7, 1975, specifically: 2,4-D, 2,4,5-T and its contaminant TCDD; cacodylic acid; and picloram. 38 C.F.R. § 3.307 (a)(6)(i).

A Veteran who served between April 1, 1968, and August 31, 1971, in a unit that, as determined by the Department of Defense, operated in or near the Korean DMZ in an area in which herbicides are known to have been applied during that period, shall be presumed to have been exposed during that service to an herbicide agent, unless there is affirmative evidence to establish that the Veteran was not exposed to any herbicide agent during that service. 38 C.F.R. § 3.307.

The AOJ found that the Veteran has a current diagnosis for Parkinson’s disease. The Veteran contends Parkinson’s disease is related to service in the demilitarized zone (DMZ) in Korea.

The Veteran’s service personnel records show that the Veteran served in Korea. He was stationed with A Battery, 1/15 FA 2nd Infantry Division and the HHB 1/15 FA 2nd Infantry Division, and he served as a cannoneer. The Veteran has stated that he served for three weeks in the DMZ, and while there, he ate, slept, and worked in trenches and underground bunkers.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Davidson v. SHINSEKI
581 F.3d 1313 (Federal Circuit, 2009)
Fagan v. Shinseki
573 F.3d 1282 (Federal Circuit, 2009)
Skoczen v. Shinseki
564 F.3d 1319 (Federal Circuit, 2009)
Jandreau v. Nicholson
492 F.3d 1372 (Federal Circuit, 2007)
Swann v. Brown
5 Vet. App. 229 (Veterans Claims, 1993)
Godfrey v. Brown
8 Vet. App. 113 (Veterans Claims, 1995)
Sanchez-Benitez v. West
13 Vet. App. 282 (Veterans Claims, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
181011-676, Counsel Stack Legal Research, https://law.counselstack.com/opinion/181011-676-bva-2019.